846 results on '"Leong, Rupert W"'
Search Results
2. Intensified versus standard dose infliximab induction therapy for steroid-refractory acute severe ulcerative colitis (PREDICT-UC): an open-label, multicentre, randomised controlled trial
3. Effects of Thiopurine Withdrawal on Vedolizumab-Treated Patients With Ulcerative Colitis: A Randomized Controlled Trial
4. CORE-IBD: A Multidisciplinary International Consensus Initiative to Develop a Core Outcome Set for Randomized Controlled Trials in Inflammatory Bowel Disease
5. Consensus Statements on Assessments and Vaccinations Prior to Commencement of Advanced Therapies for the Treatment of Inflammatory Bowel Diseases.
6. Review article: Optimisation of biologic (monoclonal antibody) therapeutic response in inflammatory bowel disease.
7. The Disease Severity Index for Inflammatory Bowel Disease Is a Valid Instrument that Predicts Complicated Disease.
8. Lyophilised oral faecal microbiota transplantation for ulcerative colitis (LOTUS): a randomised, double-blind, placebo-controlled trial
9. Two vs One Forward View Examination of Right Colon on Adenoma Detection: An International Multicenter Randomized Trial
10. Letter: Early real‐world evidence from the United Arab Emirates of the persistence, effectiveness and safety of risankizumab for the treatment of Crohn's disease—Authors' reply
11. Letter: Intestinal permeability accounting for ongoing gastrointestinal symptoms following endoscopic remission in IBD
12. Ten missteps in the management of inflammatory bowel disease in Asia: An expert report by the Asian Pacific Association of Gastroenterology Working Group on Inflammatory Bowel Disease
13. Intravenous Versus Subcutaneous Infliximab in Inflammatory Bowel Disease: A Systematic Review and Meta-analysis.
14. Refining microbial community metabolic models derived from metagenomics using reference-based taxonomic profiling.
15. Biological Agents in the Treatment of Crohn's Disease: A Propensity Score-Matched Analysis From the Prospective Persistence Australian National IBD Cohort (PANIC3) Study.
16. The role of faecal microbiota transplantation in the treatment of inflammatory bowel disease
17. Ustekinumab Pharmacokinetics and Exposure Response in a Phase 3 Randomized Trial of Patients With Ulcerative Colitis
18. Meta‐analysis: Persistence of advanced therapies in the treatment of inflammatory bowel disease
19. Multi-modal conservative management of intra-abdominal collections in fistulising Crohn’s disease
20. Eldelumab [Anti-IP-10] Induction Therapy for Ulcerative Colitis: A Randomised, Placebo-Controlled, Phase 2b Study
21. Efficacy and Safety of Ustekinumab for Ulcerative Colitis Through 4 Years: Final Results of the UNIFI Long-Term Maintenance Study
22. Early thiopurine maintenance and reduced colectomy rate in ulcerative colitis: fact or fiction?
23. Early thiopurine maintenance is associated with reduced proximal disease progression and colectomy rate in ulcerative colitis
24. The Disease Severity Index for Inflammatory Bowel Disease Is a Valid Instrument that Predicts Complicated Disease
25. Comparing persistence of new biologics to conventional anti-TNF alphas in adult patients with inflammatory bowel disease: a systematic review and meta-analysis protocol
26. Key metabolomic alterations are associated with ulcerative colitis disease state and activity: a validation analysis
27. Real-world experience with subcutaneous infliximab: broadening treatment strategies for inflammatory bowel disease
28. Impaired Intestinal Permeability Contributes to Ongoing Bowel Symptoms in Patients With Inflammatory Bowel Disease and Mucosal Healing
29. Full-Spectrum Endoscopy Improves Surveillance for Dysplasia in Patients With Inflammatory Bowel Diseases
30. Multidonor intensive faecal microbiota transplantation for active ulcerative colitis: a randomised placebo-controlled trial
31. Spp24 is associated with endocytic signalling, lipid metabolism, and discrimination of tissue integrity for ‘leaky-gut’ in inflammatory bowel disease
32. Gastroenterologists’ preference and risk perception on the use of immunomodulators and biological therapies in elderly patients with ulcerative colitis: an international survey
33. Limited applicability of chromoendoscopy-guided confocal laser endomicroscopy as daily-practice surveillance strategy in Crohn’s disease
34. The learning curve, interobserver, and intraobserver agreement of endoscopic confocal laser endomicroscopy in the assessment of mucosal barrier defects
35. Comorbidities Rather Than Age Are Associated With the Use of Immunomodulators in Elderly-onset Inflammatory Bowel Disease
36. The Accuracy of Adherence Self-report Scales in Patients on Thiopurines for Inflammatory Bowel Disease: A Comparison With Drug Metabolite Levels and Medication Possession Ratios
37. Adalimumab originator versus adalimumab biosimilars in inflammatory bowel disease in Australia
38. Australian inflammatory bowel disease consensus statements for preconception, pregnancy and breast feeding
39. Robust SARS-CoV-2 antibody and T cell immunity following three COVID-19 vaccine doses in inflammatory bowel disease patients receiving anti-TNF or alternative treatments
40. Inflammatory Bowel Disease Environmental Risk Factors: A Population-Based Case–Control Study of Middle Eastern Migration to Australia
41. Crohn's disease management after intestinal resection: a randomised trial
42. Proteomics in Inflammatory Bowel Disease: Approach Using Animal Models
43. Knowledge and attitudes towards the use of histological assessments in ulcerative colitis by gastroenterologists vs pathologists
44. IBD barriers across the continents: a continent-specific analysis – Australasia
45. Planning to conceive within a year is associated with better pregnancy-specific disease-related patient knowledge and better medication adherence in women of childbearing age with inflammatory bowel disease
46. Robust SARS-CoV-2 antibody and T cell immunity following three COVID-19 vaccine doses in inflammatory bowel disease patients receiving anti-TNF or alternative treatments
47. Faecal microbiota transplantation for recurrent C. difficile infections: challenges and improvement opportunities for clinical practice and healthcare systems
48. Tryptophan Metabolism ‘Hub’ Gene Expression Associates with Increased Inflammation and Severe Disease Outcomes in COVID-19 Infection and Inflammatory Bowel Disease
49. Relationship between disease severity and quality of life and assessment of health care utilization and cost for ulcerative colitis in Australia: A cross-sectional, observational study
50. Implementation of Image-enhanced Endoscopy into Solo and Group Practices for Dysplasia Detection in Crohn's Disease and Ulcerative Colitis
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.